Mr Thomas Friedmann > Dechert LLP > Boston, United States > Lawyer Profile

Dechert LLP Offices

Dechert LLP
ONE INTERNATIONAL PLACE
40TH FLOOR, 100 OLIVER STREET
BOSTON, MA 02110-2605
MASSACHUSETTS
United States
Visit website 1 617 728 7100 1 617 426 6567

Mr Thomas Friedmann

Thomas Friedmann photo
+1 617 728 7120 thomas.friedmann@dechert.com

Work Department

Corporate Finance and Capital Markets

Position

Partner

Career

Thomas J. Friedmann, managing partner of Dechert’s Boston office and co-chair of Dechert’s Global Corporate Finance and Capital Markets Practice, represents domestic and non-U.S. issuers and investment banks in public and private securities transactions. Mr. Friedmann also advises corporate clients on matters relating to securities law, corporate governance, and general corporate matters, including financial restructuring and securitization transactions.

Mr. Friedmann is also the co-head of Dechert’s Permanent Capital Practice and regularly advises alternative asset managers in their efforts to access permanent capital through Business Development Companies (BDCs), closed-end funds and other vehicles. Having represented both issuers and underwriters on the organization and listings of numerous BDCs, Mr. Friedmann assists companies in navigating securities laws and sensitive disclosure matters under the Securities Act of 1933, the Securities Exchange Act of 1934 and the Investment Company Act of 1940. He is a frequent speaker and has been quoted in various media outlets regarding developments and trends affecting BDCs and other alternative investment vehicles, an area in which Dechert has been identified as a leader by The Legal 500, a leading legal directory. Mr. Friedmann also counsels public and privately held companies in the energy, hospitality and technology industries on a broad range of capital markets and financing transactions, including high-yield and investment-grade debt offerings, convertible and equity-linked securities and private financings. In addition, he advises on general corporate matters, such as corporate governance and board issues, compliance and disclosure matters, and periodic reporting.

Education

  • University of Virginia School of Law, J.D., 1991
  • University of Virginia Darden School of Business, M.B.A., 1991
  • Harvard College, A.B., 1985, magna cum laude

Lawyer Rankings

United States > Finance > Capital markets: debt offerings

Dechert LLP is at the forefront of debt offerings by life sciences companies and permanent capital vehicles, including business development companies (BDCs). It also operates in multiple other sectors. In BDCs, the firm’s commitment to corporate and securities, securitisation and the Investment Company Act of 1940 expertise, has enabled it to standout in this area. The capital markets team primarily operates in middle market deals, though often ventures into the $1bn+ arena. Washington DC partner Harry Pangas heads the US capital markets group, which includes Boston-based co-head of the permanent capital practice, Thomas Friedmann. New York’s David Rosenthal is another key figure for life sciences sector offerings.

United States > Finance > Capital markets: equity offerings

Dechert LLP‘s capital markets practice is driven in large part by the life sciences and permanent capital vehicle clients, including business development companies (BDCs). The firm has worked on a series of notable equity deals including at-the-market offerings. Washington DC-based Harry Pangas heads the US capital markets group and is noted for his work in the BDC sector, as is Boston’s Thomas Friedmann, who co-heads the permanent capital practice. New York’s David Rosenthal co-leads the life sciences team and has extensive experience in capital markets transactions.

United States > Finance > Capital markets: global offerings

Dechert LLP has a fine record in cross-border debt and equity offerings, along with international de-SPAC transactions. It is noted for deals involving permanent capital vehicles (including business development companies) and life sciences companies. Boston’s Thomas Friedmann co-heads the capital markets group alongside life sciences specialist David Rosenthal in New York. Stephen Leitzell is another key figure in Philadelphia with particular experience in healthcare and technology.

Lawyer Rankings

Top Tier Firm Rankings

Firm Rankings